Insider Selling: Allstate (NYSE:ALL) Insider Sells $814,482.18 in Stock

The Allstate Corporation (NYSE:ALL) insider Suren Gupta sold 3,786 shares of the stock in a transaction dated Friday, November 28th. The stock was sold at an average price of $215.13, for a total value of $814,482.18. Following the sale, the insider owned 100,646 shares of the company’s stock, valued at approximately $21,651,973.98. The trade was a 3.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Suren Gupta also recently made the following trade(s):

• On Wednesday, November 26th, Suren Gupta sold 750 shares of Allstate stock. The shares were sold at an average price of $215.01, for a total value of $161,257.50.
• On Monday, November 24th, Suren Gupta sold 600 shares of Allstate stock. The stock was sold at an average price of $215.02, for a total value of $129,012.00.
• On Friday, November 21st, Suren Gupta sold 21,871 shares of Allstate stock. The stock was sold at an average price of $215.21, for a total value of $4,706,857.91.
• On Monday, November 17th, Suren Gupta sold 400 shares of Allstate stock. The stock was sold at an average price of $215.22, for a total value of $86,088.00.
• On Friday, November 14th, Suren Gupta sold 1,400 shares of Allstate stock. The stock was sold at an average price of $215.02, for a total transaction of $301,028.00.

Allstate Stock Down 0.1%

Allstate stock opened at $208.64 on Thursday. The company has a market capitalization of $54.60 billion, a PE ratio of 6.75, a PEG ratio of 0.39 and a beta of 0.25. The Allstate Corporation has a 12-month low of $176.00 and a 12-month high of $215.89. The firm’s fifty day moving average is $204.77 and its 200 day moving average is $202.52. The company has a quick ratio of 0.43, a current ratio of 0.43 and a debt-to-equity ratio of 0.32.

Allstate (NYSE:ALL) last posted its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $11.17 EPS for the quarter, topping analysts’ consensus estimates of $5.48 by $5.69. Allstate had a net margin of 12.53% and a return on equity of 35.42%. The business had revenue of $17.26 billion during the quarter, compared to analysts’ expectations of $16.59 billion. During the same period last year, the company posted $3.91 earnings per share. The business’s quarterly revenue was up 3.8% on a year-over-year basis. As a group, sell-side analysts predict that The Allstate Corporation will post 18.74 EPS for the current fiscal year.

Allstate Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 2nd. Investors of record on Monday, December 1st will be given a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend is Monday, December 1st. Allstate’s payout ratio is presently 12.95%.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. Wolfe Research raised Allstate to a “strong-buy” rating in a research note on Tuesday, September 16th. Wall Street Zen cut Allstate from a “strong-buy” rating to a “buy” rating in a report on Saturday, November 8th. Roth Capital lifted their price target on shares of Allstate from $230.00 to $240.00 and gave the company a “buy” rating in a research report on Wednesday, November 26th. Evercore ISI set a $233.00 price objective on shares of Allstate and gave the stock an “in-line” rating in a report on Wednesday, October 1st. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of Allstate in a research note on Wednesday, October 8th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $237.92.

Hedge Funds Weigh In On Allstate

Several large investors have recently bought and sold shares of ALL. Vanguard Group Inc. raised its holdings in shares of Allstate by 1.3% in the second quarter. Vanguard Group Inc. now owns 33,235,231 shares of the insurance provider’s stock valued at $6,690,584,000 after purchasing an additional 435,145 shares during the last quarter. State Street Corp grew its position in Allstate by 0.7% in the 3rd quarter. State Street Corp now owns 11,859,517 shares of the insurance provider’s stock worth $2,557,362,000 after purchasing an additional 85,468 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in Allstate by 25.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 11,709,610 shares of the insurance provider’s stock valued at $2,424,710,000 after buying an additional 2,374,684 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Allstate by 1.2% during the 2nd quarter. Geode Capital Management LLC now owns 6,714,629 shares of the insurance provider’s stock worth $1,345,961,000 after buying an additional 79,366 shares in the last quarter. Finally, Franklin Resources Inc. boosted its stake in shares of Allstate by 2.5% in the 2nd quarter. Franklin Resources Inc. now owns 4,670,113 shares of the insurance provider’s stock worth $940,140,000 after buying an additional 112,858 shares during the last quarter. 76.47% of the stock is currently owned by institutional investors.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.